Complete financial analysis of Ain Holdings Inc. (9627.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ain Holdings Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Shaftesbury Capital PLC (CCPPF) Income Statement Analysis – Financial Results
- Quad Energy Corporation (CDID) Income Statement Analysis – Financial Results
- Traka Resources Limited (TKL.AX) Income Statement Analysis – Financial Results
- Mphasis Limited (MPHASIS.BO) Income Statement Analysis – Financial Results
- SportsMap Tech Acquisition Corp. (SMAPU) Income Statement Analysis – Financial Results
Ain Holdings Inc. (9627.T)
About Ain Holdings Inc.
Ain Holdings Inc. engages in the dispensing pharmacy, and cosmetic and drug store businesses in Japan. The company's Dispensing Pharmacy segment operates dispensing pharmacies; sells generic drugs; and provides staff dispatching and introduction services, as well as consulting services. Its Cosmetic and Drug Store segment engages in the management of cosmetic and drug stores under the AINZ & TULPE brand name. The company's Other segment is involved in the retail store and real estate rental activities. As of April 30, 2021, it operated 1,065 dispensing pharmacies; and 69 cosmetic and drug stores. The company was formerly known as Ain Pharmaciez Inc. and changed its name to Ain Holdings Inc. in November 2015. Ain Holdings Inc. was incorporated in 1969 and is headquartered in Sapporo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 399.82B | 358.74B | 316.25B | 297.31B | 292.62B | 275.60B | 268.39B | 248.11B | 234.84B | 187.90B | 170.23B | 154.56B | 142.79B | 129.39B | 125.50B | 115.39B | 106.23B | 81.31B | 76.30B |
| Cost of Revenue | 340.30B | 305.04B | 266.28B | 251.15B | 245.75B | 230.23B | 220.39B | 206.02B | 196.31B | 158.94B | 144.48B | 130.12B | 119.70B | 109.30B | 108.26B | 100.14B | 92.58B | 70.45B | 66.07B |
| Gross Profit | 59.52B | 53.70B | 49.97B | 46.16B | 46.86B | 45.36B | 47.99B | 42.09B | 38.54B | 28.96B | 25.75B | 24.44B | 23.09B | 20.09B | 17.24B | 15.25B | 13.65B | 10.86B | 10.23B |
| Gross Profit Ratio | 14.89% | 14.97% | 15.80% | 15.52% | 16.01% | 16.46% | 17.88% | 16.97% | 16.41% | 15.41% | 15.13% | 15.81% | 16.17% | 15.53% | 13.74% | 13.21% | 12.85% | 13.36% | 13.41% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 28.17B | 1.17B | 997.00M | 894.00M | 879.00M | 845.00M | 806.33M | 810.63M | 743.22M | 522.91M | 504.80M | 570.69M | 1.23B | 1.22B | 1.16B | 1.12B | 857.02M | 732.88M | 656.15M |
| Selling & Marketing | 2.29B | 2.39B | 2.47B | 3.10B | 3.26B | 3.37B | 3.74B | 3.91B | 2.79B | 1.43B | 1.03B | 875.14M | 803.12M | 772.54M | 684.37M | 555.10M | 794.65M | 681.22M | 588.22M |
| SG&A | 30.47B | 3.56B | 3.47B | 4.00B | 4.14B | 4.22B | 4.55B | 4.72B | 3.53B | 1.95B | 1.53B | 1.45B | 2.03B | 1.99B | 1.85B | 1.68B | 1.65B | 1.41B | 1.24B |
| Other Expenses | 8.62B | 1.01B | 771.00M | 1.78B | 713.00M | 592.00M | 586.37M | 488.80M | 680.22M | 404.11M | 418.71M | 537.60M | 413.16M | 295.49M | 129.22M | 110.42M | 221.64M | 99.85M | 44.86M |
| Operating Expenses | 39.09B | 37.69B | 34.83B | 35.22B | 30.79B | 29.29B | 28.37B | 27.53B | 23.92B | 17.51B | 15.64B | 14.74B | 10.33B | 9.62B | 8.54B | 7.90B | 7.35B | 5.94B | 5.38B |
| Cost & Expenses | 379.39B | 342.73B | 301.10B | 286.37B | 276.54B | 259.52B | 248.76B | 233.55B | 220.22B | 176.45B | 160.11B | 144.86B | 130.03B | 118.92B | 116.80B | 108.05B | 99.93B | 76.39B | 71.45B |
| Interest Income | 52.00M | 54.00M | 41.00M | 38.00M | 55.00M | 70.00M | 65.84M | 68.12M | 58.70M | 66.34M | 76.15M | 88.66M | 59.45M | 54.97M | 52.44M | 31.79M | 26.06M | 21.83M | 10.15M |
| Interest Expense | 39.00M | 52.00M | 38.00M | 44.00M | 63.00M | 125.00M | 117.47M | 143.79M | 96.21M | 84.09M | 101.87M | 144.23M | 159.40M | 240.04M | 289.68M | 357.70M | 365.65M | 199.27M | 148.67M |
| Depreciation & Amortization | 10.89B | 9.84B | 8.93B | 8.68B | 8.44B | 8.09B | 7.53B | 7.34B | 6.20B | 4.83B | 4.29B | 4.00B | 3.01B | 2.53B | 2.17B | 1.98B | 1.70B | 1.13B | 900.27M |
| EBITDA | 30.00B | 25.80B | 24.06B | 19.43B | 24.51B | 24.13B | 26.96B | 21.79B | 20.24B | 15.75B | 14.66B | 13.84B | 12.95B | 10.42B | 8.56B | 9.46B | 8.24B | 6.17B | 5.81B |
| EBITDA Ratio | 7.50% | 7.52% | 7.88% | 7.23% | 8.65% | 9.02% | 10.37% | 9.07% | 9.19% | 8.93% | 8.77% | 9.29% | 11.38% | 10.32% | 8.80% | 8.20% | 7.76% | 7.58% | 7.61% |
| Operating Income | 20.43B | 16.00B | 15.14B | 10.93B | 16.07B | 16.07B | 19.62B | 14.56B | 14.62B | 11.45B | 10.11B | 9.70B | 12.77B | 10.47B | 8.70B | 7.34B | 6.30B | 4.92B | 4.85B |
| Operating Income Ratio | 5.11% | 4.46% | 4.79% | 3.68% | 5.49% | 5.83% | 7.31% | 5.87% | 6.23% | 6.09% | 5.94% | 6.28% | 8.94% | 8.09% | 6.93% | 6.36% | 5.93% | 6.05% | 6.36% |
| Total Other Income/Expenses | -1.35B | -122.00M | -2.01B | 835.00M | -138.00M | -443.00M | -1.77B | -255.91M | -669.59M | -619.69M | 152.50M | -6.68M | -471.77M | -2.82B | -2.60B | -2.60B | -2.59B | -2.17B | -2.20B |
| Income Before Tax | 19.08B | 15.88B | 13.13B | 11.77B | 15.93B | 15.62B | 17.85B | 14.31B | 13.95B | 10.83B | 10.27B | 9.69B | 9.78B | 7.64B | 6.11B | 4.74B | 3.71B | 2.74B | 2.65B |
| Income Before Tax Ratio | 4.77% | 4.43% | 4.15% | 3.96% | 5.44% | 5.67% | 6.65% | 5.77% | 5.94% | 5.76% | 6.03% | 6.27% | 6.85% | 5.91% | 4.86% | 4.11% | 3.49% | 3.37% | 3.48% |
| Income Tax Expense | 7.67B | 6.64B | 6.03B | 5.08B | 6.73B | 6.56B | 7.32B | 6.35B | 5.99B | 4.57B | 4.93B | 4.63B | 4.88B | 3.73B | 2.96B | 2.61B | 1.97B | 1.62B | 1.26B |
| Net Income | 11.40B | 9.23B | 7.09B | 6.70B | 9.18B | 9.03B | 10.57B | 7.95B | 7.92B | 6.20B | 5.26B | 5.08B | 4.90B | 3.92B | 3.13B | 2.13B | 1.62B | 1.01B | 1.22B |
| Net Income Ratio | 2.85% | 2.57% | 2.24% | 2.25% | 3.14% | 3.28% | 3.94% | 3.20% | 3.37% | 3.30% | 3.09% | 3.28% | 3.43% | 3.03% | 2.50% | 1.84% | 1.52% | 1.24% | 1.59% |
| EPS | 324.63 | 262.86 | 201.46 | 189.03 | 259.09 | 254.86 | 310.08 | 250.71 | 249.69 | 195.45 | 165.04 | 159.19 | 153.68 | 127.84 | 114.04 | 85.37 | 71.18 | 44.67 | 52.27 |
| EPS Diluted | 324.63 | 262.86 | 201.46 | 189.03 | 259.09 | 254.86 | 310.08 | 250.71 | 249.69 | 195.45 | 165.04 | 159.19 | 153.68 | 127.84 | 113.97 | 85.14 | 70.91 | 44.35 | 51.60 |
| Weighted Avg Shares Out | 35.12M | 35.13M | 35.20M | 35.43M | 35.43M | 35.43M | 34.08M | 31.71M | 31.71M | 31.71M | 31.87M | 31.88M | 31.88M | 30.64M | 27.46M | 24.93M | 22.70M | 22.62M | 22.52M |
| Weighted Avg Shares Out (Dil) | 35.12M | 35.13M | 35.20M | 35.43M | 35.43M | 35.43M | 34.08M | 31.71M | 31.71M | 31.71M | 31.87M | 31.88M | 31.88M | 30.64M | 27.47M | 24.99M | 22.79M | 22.79M | 23.56M |
Source: https://incomestatements.info
Category: Stock Reports